PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Bioengineering, Guangdong Province Engineering Research Center of Antibody Drug and Immunoassay, College of Life Science and Technology, Jinan University, Guangzhou, 510632, People\'s Republic of China.\', \'Guangdong Biowings Tech Limited, Foshan, 528000, People\'s Republic of China.\', \'Department of Laboratory Medicine, Guangdong Second Provincial General Hospital, Guangzhou, 510317, People\'s Republic of China.\', \'Department of Laboratory Medicine, Guangdong Second Provincial General Hospital, Guangzhou, 510317, People\'s Republic of China. liangshan8027@163.com.\', \'Department of Laboratory Medicine, Guangdong Second Provincial General Hospital, Guangzhou, 510317, People\'s Republic of China. caodl@126.com.\', \'Department of Bioengineering, Guangdong Province Engineering Research Center of Antibody Drug and Immunoassay, College of Life Science and Technology, Jinan University, Guangzhou, 510632, People\'s Republic of China. tyjaq7926@163.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s12951-021-01021-0
?:doi
?:hasPublicationType
?:journal
  • Journal of nanobiotechnology
is ?:pmid of
?:pmid
?:pmid
  • 34496881
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.38
?:rankingScore_hIndex
  • 51
?:title
  • Application of the amplification-free SERS-based CRISPR/Cas12a platform in the identification of SARS-CoV-2 from clinical samples.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all